Latest | F'cast | |
---|---|---|
Div Yield | 0.7% | |
Div Cover | 4.0 | |
Op Mrgn | 23.6% | |
ROCE | 33.1% |
Latest | F'cast | |
---|---|---|
P/E | 35.5 | |
PEG | 0.2 | |
Pr/Revenue | 6.7 | |
Pr/Book | 3.8 |
Latest | F'cast | |
---|---|---|
Revenue | 15.3% | |
PBT | 163.7% | |
EPS | 209.9% | |
DPS | 2.2% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 6,879.81 | 1,479.33 | 743.96¢ | 26.5 | 0.8 | +33% | 141.82¢ | 0.0% |
31-Dec-26 | 7,794.16 | 2,066.20 | 958.35¢ | 20.6 | 0.7 | +29% | 145.84¢ | 0.0% |
31-Dec-27 | 8,760.82 | 2,737.25 | 1,220.30¢ | 16.2 | 0.6 | +27% | 148.99¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Currency | Euro |
Share Price | 197.30 |
Change Today | -1.70 |
% Change | -0.85 % |
52 Week High | 200.50 |
52 Week Low | 129.35 |
Volume | 144,003 |
Shares Issued | 190.00m |
Market Cap | 37,487m |
Beta | 1.64 |
Strong Buy | 7 |
Buy | 10 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
17:35 | 29 @ 197.30 |
17:35 | 114 @ 197.30 |
17:35 | 104 @ 197.30 |
17:35 | 62 @ 197.30 |
17:35 | 62 @ 197.30 |
You are here: research